Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients
To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard. Seventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic a...
Saved in:
Published in | Clinical radiology Vol. 69; no. 5; pp. 473 - 480 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.05.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 0009-9260 1365-229X 1365-229X |
DOI | 10.1016/j.crad.2013.12.003 |
Cover
Abstract | To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard.
Seventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic acid-enhanced DCE-MRI were divided into three subgroups: no (A0, n = 31), mild (A1, n = 27), and moderate–severe (A2–A3, n = 21) activities. Two DCE-MRI models were measured: (1) a dual-input single-compartment model to obtain absolute arterial, portal venous, and total blood flow, arterial fraction (ART), distribution volume, and mean transit time; (2) a curve analysis method to obtain peak, slope, and AUC (area under curve). The serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels also obtained. Statistical testing included Kruskal–Wallis tests for continuous data, Pearson's correlation tests, and multiple linear regression analyses.
Hepatic necro-inflammatory activity grades were significantly correlated with fibrotic stages, serum ALT level, ART and AUC. ART was helpful to predict the mild activity (≤A1 versus >A1; Az = 0.728), whereas AUC could differentiate no activity from any activity (A0 versus >A0; Az = 0.703). Peak, slope and AUC were all associated with AST and ALT (p < 0.05).
Gadoxetic acid-enhanced DCE-MRI parameters may be used to evaluate the severity of hepatic necro-inflammation and function. |
---|---|
AbstractList | To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard.
Seventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic acid-enhanced DCE-MRI were divided into three subgroups: no (A0, n = 31), mild (A1, n = 27), and moderate–severe (A2–A3, n = 21) activities. Two DCE-MRI models were measured: (1) a dual-input single-compartment model to obtain absolute arterial, portal venous, and total blood flow, arterial fraction (ART), distribution volume, and mean transit time; (2) a curve analysis method to obtain peak, slope, and AUC (area under curve). The serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels also obtained. Statistical testing included Kruskal–Wallis tests for continuous data, Pearson's correlation tests, and multiple linear regression analyses.
Hepatic necro-inflammatory activity grades were significantly correlated with fibrotic stages, serum ALT level, ART and AUC. ART was helpful to predict the mild activity (≤A1 versus >A1; Az = 0.728), whereas AUC could differentiate no activity from any activity (A0 versus >A0; Az = 0.703). Peak, slope and AUC were all associated with AST and ALT (p < 0.05).
Gadoxetic acid-enhanced DCE-MRI parameters may be used to evaluate the severity of hepatic necro-inflammation and function. To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard.AIMTo evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard.Seventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic acid-enhanced DCE-MRI were divided into three subgroups: no (A0, n = 31), mild (A1, n = 27), and moderate-severe (A2-A3, n = 21) activities. Two DCE-MRI models were measured: (1) a dual-input single-compartment model to obtain absolute arterial, portal venous, and total blood flow, arterial fraction (ART), distribution volume, and mean transit time; (2) a curve analysis method to obtain peak, slope, and AUC (area under curve). The serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels also obtained. Statistical testing included Kruskal-Wallis tests for continuous data, Pearson's correlation tests, and multiple linear regression analyses.MATERIALS AND METHODSSeventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic acid-enhanced DCE-MRI were divided into three subgroups: no (A0, n = 31), mild (A1, n = 27), and moderate-severe (A2-A3, n = 21) activities. Two DCE-MRI models were measured: (1) a dual-input single-compartment model to obtain absolute arterial, portal venous, and total blood flow, arterial fraction (ART), distribution volume, and mean transit time; (2) a curve analysis method to obtain peak, slope, and AUC (area under curve). The serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels also obtained. Statistical testing included Kruskal-Wallis tests for continuous data, Pearson's correlation tests, and multiple linear regression analyses.Hepatic necro-inflammatory activity grades were significantly correlated with fibrotic stages, serum ALT level, ART and AUC. ART was helpful to predict the mild activity (≤ A1 versus >A1; Az = 0.728), whereas AUC could differentiate no activity from any activity (A0 versus >A0; Az = 0.703). Peak, slope and AUC were all associated with AST and ALT (p < 0.05).RESULTSHepatic necro-inflammatory activity grades were significantly correlated with fibrotic stages, serum ALT level, ART and AUC. ART was helpful to predict the mild activity (≤ A1 versus >A1; Az = 0.728), whereas AUC could differentiate no activity from any activity (A0 versus >A0; Az = 0.703). Peak, slope and AUC were all associated with AST and ALT (p < 0.05).Gadoxetic acid-enhanced DCE-MRI parameters may be used to evaluate the severity of hepatic necro-inflammation and function.CONCLUSIONGadoxetic acid-enhanced DCE-MRI parameters may be used to evaluate the severity of hepatic necro-inflammation and function. Aim To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard. Materials and methods Seventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic acid-enhanced DCE-MRI were divided into three subgroups: no (A0, n = 31), mild (A1, n = 27), and moderate–severe (A2–A3, n = 21) activities. Two DCE-MRI models were measured: (1) a dual-input single-compartment model to obtain absolute arterial, portal venous, and total blood flow, arterial fraction (ART), distribution volume, and mean transit time; (2) a curve analysis method to obtain peak, slope, and AUC (area under curve). The serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels also obtained. Statistical testing included Kruskal–Wallis tests for continuous data, Pearson's correlation tests, and multiple linear regression analyses. Results Hepatic necro-inflammatory activity grades were significantly correlated with fibrotic stages, serum ALT level, ART and AUC. ART was helpful to predict the mild activity (≤A1 versus >A1; Az = 0.728), whereas AUC could differentiate no activity from any activity (A0 versus >A0; Az = 0.703). Peak, slope and AUC were all associated with AST and ALT ( p < 0.05). Conclusion Gadoxetic acid-enhanced DCE-MRI parameters may be used to evaluate the severity of hepatic necro-inflammation and function. To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard. Seventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic acid-enhanced DCE-MRI were divided into three subgroups: no (A0, n = 31), mild (A1, n = 27), and moderate-severe (A2-A3, n = 21) activities. Two DCE-MRI models were measured: (1) a dual-input single-compartment model to obtain absolute arterial, portal venous, and total blood flow, arterial fraction (ART), distribution volume, and mean transit time; (2) a curve analysis method to obtain peak, slope, and AUC (area under curve). The serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels also obtained. Statistical testing included Kruskal-Wallis tests for continuous data, Pearson's correlation tests, and multiple linear regression analyses. Hepatic necro-inflammatory activity grades were significantly correlated with fibrotic stages, serum ALT level, ART and AUC. ART was helpful to predict the mild activity (≤ A1 versus >A1; Az = 0.728), whereas AUC could differentiate no activity from any activity (A0 versus >A0; Az = 0.703). Peak, slope and AUC were all associated with AST and ALT (p < 0.05). Gadoxetic acid-enhanced DCE-MRI parameters may be used to evaluate the severity of hepatic necro-inflammation and function. |
Author | Liang, P.-C. Hwang, R.-M. Kao, J.-H. Shih, T.T.-F. Hsu, C.-Y. Chen, B.-B. Wei, S.-Y. Yu, C.-W. Lee, H.-S. |
Author_xml | – sequence: 1 givenname: B.-B. surname: Chen fullname: Chen, B.-B. organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China – sequence: 2 givenname: C.-Y. surname: Hsu fullname: Hsu, C.-Y. email: joyhcy@gmail.com organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China – sequence: 3 givenname: C.-W. surname: Yu fullname: Yu, C.-W. organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China – sequence: 4 givenname: J.-H. surname: Kao fullname: Kao, J.-H. organization: Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China – sequence: 5 givenname: H.-S. surname: Lee fullname: Lee, H.-S. organization: Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China – sequence: 6 givenname: P.-C. surname: Liang fullname: Liang, P.-C. organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China – sequence: 7 givenname: S.-Y. surname: Wei fullname: Wei, S.-Y. organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China – sequence: 8 givenname: R.-M. surname: Hwang fullname: Hwang, R.-M. organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China – sequence: 9 givenname: T.T.-F. surname: Shih fullname: Shih, T.T.-F. organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24556468$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks1u1DAUhS1URKeFF2CBvGSTYDt2JqkQEqpKW6kIiR-JnWXsmxkPiTO1nYHpQ_DM2E1hUYmyurr2Ob7yd-4ROnCjA4SeU1JSQutXm1J7ZUpGaFVSVhJSPUILWtWiYKz9eoAWhJC2aFlNDtFRCJvccsafoEPGhah53SzQrwvYqmg1dqD9WFjX9WoY0snosHIGQw87FcHg3u7AY3A3-wHCCT7bqX6aZT9sXOP3Hy_xFnw3hXxkB7WybjVfrZQZf0KeobQ12Dqs1350qV_fzo424FzBxfAUPe5UH-DZXT1GX96dfT69KK4-nF-evr0qNK9ZLOiy1a3oaN1CwzqgjHBoDKtaobsWoNV02XQdWTZVDYQuuRacGsMbrrVhNAmP0cv53a0frycIUQ42aOh75WCcgqSCMiFEwpSkL-6k07cBjNz69Du_l38YJgGbBQlgCB66vxJKZA5KbmQOSuagJGUyBZVMzT2TtvGWZ_TK9g9bX89WSIB2FrwMOsHTYKwHHaUZ7cP2N_fsurcpDdV_hz2EzTh5l9BLKkMyyE95a_IO0YoQsWSZ3cm_H_jf9N-y_dia |
CitedBy_id | crossref_primary_10_1159_000367742 crossref_primary_10_1371_journal_pone_0197213 crossref_primary_10_1259_bjr_20201377 crossref_primary_10_3348_kjr_2024_0335 crossref_primary_10_1016_j_mri_2022_01_002 crossref_primary_10_1007_s00330_019_06179_8 crossref_primary_10_1177_0300060521997586 crossref_primary_10_1371_journal_pone_0215752 crossref_primary_10_1371_journal_pone_0193929 |
Cites_doi | 10.1053/j.gastro.2008.02.075 10.1097/RLI.0b013e3181f9c487 10.1002/hep.1840190629 10.1002/mrm.10045 10.1136/gut.52.11.1638 10.1002/jmri.10176 10.1148/radiol.2463070077 10.2307/2532051 10.1093/clinchem/46.12.2050 10.1111/j.1572-0241.2002.06038.x 10.1002/hep.21513 10.1007/s00330-011-2249-5 10.1016/S1499-3872(12)60165-9 10.1136/gut.2006.115410 10.1148/radiol.10100995 10.1152/physrev.00027.2008 10.1371/journal.pone.0032622 10.1097/RLI.0b013e3182652fb9 10.1007/s00535-011-0513-8 10.1016/j.ejrad.2011.02.053 10.1002/jmri.23907 10.1148/radiol.2292021128 10.1007/s00330-012-2583-2 10.1148/radiol.12110337 10.1016/j.jhep.2007.07.022 10.1097/RLI.0b013e318200f67d 10.2214/ajr.176.3.1760667 10.1007/s00330-011-2316-y 10.1148/radiol.10100621 10.1053/crad.2001.0762 10.2214/AJR.10.5439 10.1053/gast.2003.50018 10.1002/jmri.23691 10.1016/0168-8278(95)80226-6 10.1007/s00330-012-2486-2 10.1002/hep.510240201 10.1097/RLI.0b013e3181a24512 10.2174/157340507780619179 10.2214/AJR.10.4387 |
ContentType | Journal Article |
Copyright | 2013 The Royal College of Radiologists The Royal College of Radiologists Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2013 The Royal College of Radiologists – notice: The Royal College of Radiologists – notice: Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.crad.2013.12.003 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-229X |
EndPage | 480 |
ExternalDocumentID | 24556468 10_1016_j_crad_2013_12_003 S0009926013005722 1_s2_0_S0009926013005722 |
Genre | Evaluation Studies Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29B 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABMAC ABMZM ABXDB ACDAQ ACGFS ACIEU ACRLP ACVFH ADBBV ADCNI ADEZE AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEI HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM M27 M41 MO0 N9A O-L O9- OAUVE OI~ OU0 OVD OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K TEORI UHS UV1 WH7 WUQ X7M Z5R ZGI ZXP ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 AAYXX ACLOT CITATION ~HD AGRNS CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c462t-179c95f169e82fe1204e8d2395cf9ee9c178ff07836e0174c541dd484ccd21d23 |
IEDL.DBID | .~1 |
ISSN | 0009-9260 1365-229X |
IngestDate | Sat Sep 27 23:22:38 EDT 2025 Mon Jul 21 06:02:49 EDT 2025 Wed Oct 01 05:23:03 EDT 2025 Thu Apr 24 23:05:00 EDT 2025 Fri Feb 23 02:19:08 EST 2024 Sun Feb 23 10:20:30 EST 2025 Tue Aug 26 16:32:31 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-179c95f169e82fe1204e8d2395cf9ee9c178ff07836e0174c541dd484ccd21d23 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
PMID | 24556468 |
PQID | 1512555455 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1512555455 pubmed_primary_24556468 crossref_primary_10_1016_j_crad_2013_12_003 crossref_citationtrail_10_1016_j_crad_2013_12_003 elsevier_sciencedirect_doi_10_1016_j_crad_2013_12_003 elsevier_clinicalkeyesjournals_1_s2_0_S0009926013005722 elsevier_clinicalkey_doi_10_1016_j_crad_2013_12_003 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-05-01 |
PublicationDateYYYYMMDD | 2014-05-01 |
PublicationDate_xml | – month: 05 year: 2014 text: 2014-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Clinical radiology |
PublicationTitleAlternate | Clin Radiol |
PublicationYear | 2014 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Hagiwara, Rusinek, Lee (bib10) 2008; 246 Van Beers, Leconte, Materne (bib27) 2001; 176 Padhani, Husband (bib36) 2001; 56 Chen, Hsu, Yu (bib23) 2012; 22 Katsube, Okada, Kumano (bib17) 2011; 46 Ghany, Kleiner, Alter (bib2) 2003; 124 Materne, Smith, Peeters (bib28) 2002; 47 Zech, Vos, Nordell (bib32) 2009; 44 Kumar, Sarin, Hissar (bib9) 2008; 134 Annet, Materne, Danse (bib29) 2003; 229 Vollmar, Menger (bib39) 2009; 89 Watanabe, Kanematsu, Goshima (bib16) 2011; 259 Sourbron, Sommer, Reiser (bib11) 2012; 263 Chen, Hsu, Yu (bib18) 2012; 47 van Kessel, Veldhuis, van den Bosch (bib12) 2012; 22 Feuerlein, Boll, Gupta (bib31) 2011; 196 Noren, Forsgren, Dahlqvist Leinhard (bib15) 2013; 23 Desmet, Gerber, Hoofnagle (bib25) 1994; 19 Asselah, Boyer, Guimont (bib1) 2003; 52 Choi, Kim, Park (bib13) 2011; 197 Okada, Ishii, Numata (bib20) 2012; 11 Ishak, Baptista, Bianchi (bib24) 1995; 22 Yankeelov, Gore (bib35) 2009; 3 Motosugi, Ichikawa, Sano (bib30) 2011; 46 Seto, Lai, Ip (bib7) 2012; 7 Bedossa, Poynard (bib26) 1996; 24 Onishi, Kim, Imai (bib14) 2012; 22 Nishie, Asayama, Ishigami (bib22) 2012; 36 Lok, McMahon (bib3) 2007; 45 Huang, Hsieh, Dai (bib4) 2007; 56 Lai, Hyatt, Nasser (bib8) 2007; 47 Chen, Hsu, Yu (bib38) 2011; 258 Dufour, Lott, Nolte (bib6) 2000; 46 Regev, Berho, Jeffers (bib5) 2002; 97 Lin (bib33) 1989; 45 Liao, Lewis (bib34) 2000; 54 Utsunomiya, Shimada, Hanaoka (bib19) 2012; 47 Nishie, Ushijima, Tajima (bib21) 2012; 81 Saito, Ledsam, Sourbron (bib40) 2013; 37 Padhani (bib37) 2002; 16 Asselah (10.1016/j.crad.2013.12.003_bib1) 2003; 52 Onishi (10.1016/j.crad.2013.12.003_bib14) 2012; 22 Van Beers (10.1016/j.crad.2013.12.003_bib27) 2001; 176 Liao (10.1016/j.crad.2013.12.003_bib34) 2000; 54 Dufour (10.1016/j.crad.2013.12.003_bib6) 2000; 46 Chen (10.1016/j.crad.2013.12.003_bib38) 2011; 258 Chen (10.1016/j.crad.2013.12.003_bib18) 2012; 47 Okada (10.1016/j.crad.2013.12.003_bib20) 2012; 11 Ishak (10.1016/j.crad.2013.12.003_bib24) 1995; 22 Regev (10.1016/j.crad.2013.12.003_bib5) 2002; 97 Kumar (10.1016/j.crad.2013.12.003_bib9) 2008; 134 Ghany (10.1016/j.crad.2013.12.003_bib2) 2003; 124 Lok (10.1016/j.crad.2013.12.003_bib3) 2007; 45 Utsunomiya (10.1016/j.crad.2013.12.003_bib19) 2012; 47 Nishie (10.1016/j.crad.2013.12.003_bib22) 2012; 36 Lai (10.1016/j.crad.2013.12.003_bib8) 2007; 47 Yankeelov (10.1016/j.crad.2013.12.003_bib35) 2009; 3 Huang (10.1016/j.crad.2013.12.003_bib4) 2007; 56 Sourbron (10.1016/j.crad.2013.12.003_bib11) 2012; 263 Noren (10.1016/j.crad.2013.12.003_bib15) 2013; 23 Padhani (10.1016/j.crad.2013.12.003_bib37) 2002; 16 Katsube (10.1016/j.crad.2013.12.003_bib17) 2011; 46 Zech (10.1016/j.crad.2013.12.003_bib32) 2009; 44 Feuerlein (10.1016/j.crad.2013.12.003_bib31) 2011; 196 Motosugi (10.1016/j.crad.2013.12.003_bib30) 2011; 46 Padhani (10.1016/j.crad.2013.12.003_bib36) 2001; 56 Choi (10.1016/j.crad.2013.12.003_bib13) 2011; 197 Lin (10.1016/j.crad.2013.12.003_bib33) 1989; 45 Chen (10.1016/j.crad.2013.12.003_bib23) 2012; 22 Watanabe (10.1016/j.crad.2013.12.003_bib16) 2011; 259 Annet (10.1016/j.crad.2013.12.003_bib29) 2003; 229 van Kessel (10.1016/j.crad.2013.12.003_bib12) 2012; 22 Saito (10.1016/j.crad.2013.12.003_bib40) 2013; 37 Seto (10.1016/j.crad.2013.12.003_bib7) 2012; 7 Hagiwara (10.1016/j.crad.2013.12.003_bib10) 2008; 246 Desmet (10.1016/j.crad.2013.12.003_bib25) 1994; 19 Bedossa (10.1016/j.crad.2013.12.003_bib26) 1996; 24 Nishie (10.1016/j.crad.2013.12.003_bib21) 2012; 81 Vollmar (10.1016/j.crad.2013.12.003_bib39) 2009; 89 Materne (10.1016/j.crad.2013.12.003_bib28) 2002; 47 |
References_xml | – volume: 81 start-page: 1100 year: 2012 end-page: 1104 ident: bib21 article-title: Quantitative analysis of liver function using superparamagnetic iron oxide- and Gd-EOB-DTPA-enhanced MRI: comparison with technetium-99m galactosyl serum albumin scintigraphy publication-title: Eur J Radiol – volume: 36 start-page: 664 year: 2012 end-page: 671 ident: bib22 article-title: MR prediction of liver fibrosis using a liver-specific contrast agent: Superparamagnetic iron oxide versus Gd-EOB-DTPA publication-title: J Magn Reson Imaging – volume: 56 start-page: 736 year: 2007 end-page: 737 ident: bib4 article-title: The incidence and risks of liver biopsy in non-cirrhotic patients: an evaluation of 3806 biopsies publication-title: Gut – volume: 19 start-page: 1513 year: 1994 end-page: 1520 ident: bib25 article-title: Classification of chronic hepatitis: diagnosis, grading and staging publication-title: Hepatology – volume: 46 start-page: 277 year: 2011 end-page: 283 ident: bib17 article-title: Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging publication-title: Invest Radiol – volume: 259 start-page: 142 year: 2011 end-page: 150 ident: bib16 article-title: Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging—preliminary observations publication-title: Radiology – volume: 3 start-page: 91 year: 2009 end-page: 107 ident: bib35 article-title: Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples publication-title: Curr Med Imaging Rev – volume: 22 start-page: 171 year: 2012 end-page: 180 ident: bib23 article-title: Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients publication-title: Eur Radiol – volume: 176 start-page: 667 year: 2001 end-page: 673 ident: bib27 article-title: Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity publication-title: AJR Am J Roentgenol – volume: 229 start-page: 409 year: 2003 end-page: 414 ident: bib29 article-title: Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension publication-title: Radiology – volume: 196 start-page: W18 year: 2011 end-page: W24 ident: bib31 article-title: Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein publication-title: AJR Am J Roentgenol – volume: 22 start-page: 845 year: 2012 end-page: 854 ident: bib14 article-title: Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT publication-title: Eur Radiol – volume: 258 start-page: 821 year: 2011 end-page: 831 ident: bib38 article-title: Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission publication-title: Radiology – volume: 16 start-page: 407 year: 2002 end-page: 422 ident: bib37 article-title: Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions publication-title: J Magn Reson Imaging – volume: 47 start-page: 470 year: 2012 end-page: 476 ident: bib19 article-title: Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve publication-title: J Gastroenterol – volume: 56 start-page: 607 year: 2001 end-page: 620 ident: bib36 article-title: Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies publication-title: Clin Radiol – volume: 134 start-page: 1376 year: 2008 end-page: 1384 ident: bib9 article-title: Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT publication-title: Gastroenterology – volume: 37 start-page: 1109 year: 2013 end-page: 1114 ident: bib40 article-title: Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol publication-title: J Magn Reson Imaging – volume: 197 start-page: 399 year: 2011 end-page: 405 ident: bib13 article-title: Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics publication-title: AJR Am J Roentgenol – volume: 47 start-page: 760 year: 2007 end-page: 767 ident: bib8 article-title: The clinical significance of persistently normal ALT in chronic hepatitis B infection publication-title: J Hepatol – volume: 44 start-page: 305 year: 2009 end-page: 310 ident: bib32 article-title: Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA publication-title: Invest Radiol – volume: 263 start-page: 874 year: 2012 end-page: 883 ident: bib11 article-title: Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging publication-title: Radiology – volume: 23 start-page: 174 year: 2013 end-page: 181 ident: bib15 article-title: Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA publication-title: Eur Radiol – volume: 45 start-page: 507 year: 2007 end-page: 539 ident: bib3 article-title: Chronic hepatitis B publication-title: Hepatology – volume: 97 start-page: 2614 year: 2002 end-page: 2618 ident: bib5 article-title: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection publication-title: Am J Gastroenterol – volume: 47 start-page: 649 year: 2012 end-page: 655 ident: bib18 article-title: Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic Acid publication-title: Invest Radiol – volume: 46 start-page: 141 year: 2011 end-page: 145 ident: bib30 article-title: Double-dose gadoxetic acid-enhanced magnetic resonance imaging in patients with chronic liver disease publication-title: Invest Radiol – volume: 124 start-page: 97 year: 2003 end-page: 104 ident: bib2 article-title: Progression of fibrosis in chronic hepatitis C publication-title: Gastroenterology – volume: 47 start-page: 135 year: 2002 end-page: 142 ident: bib28 article-title: Assessment of hepatic perfusion parameters with dynamic MRI publication-title: Magn Reson Med – volume: 54 start-page: 23 year: 2000 end-page: 26 ident: bib34 article-title: A note on concordance correlation coefficient publication-title: PDA J Pharm Sci Technol – volume: 24 start-page: 289 year: 1996 end-page: 293 ident: bib26 article-title: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group publication-title: Hepatology – volume: 46 start-page: 2050 year: 2000 end-page: 2068 ident: bib6 article-title: Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring publication-title: Clin Chem – volume: 7 start-page: e32622 year: 2012 ident: bib7 article-title: A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B publication-title: PLoS One – volume: 45 start-page: 255 year: 1989 end-page: 268 ident: bib33 article-title: A concordance correlation coefficient to evaluate reproducibility publication-title: Biometrics – volume: 22 start-page: 696 year: 1995 end-page: 699 ident: bib24 article-title: Histological grading and staging of chronic hepatitis publication-title: J Hepatol – volume: 22 start-page: 2153 year: 2012 end-page: 2160 ident: bib12 article-title: MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation publication-title: Eur Radiol – volume: 11 start-page: 307 year: 2012 end-page: 313 ident: bib20 article-title: Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function? publication-title: Hepatobiliary Pancreat Dis Int – volume: 246 start-page: 926 year: 2008 end-page: 934 ident: bib10 article-title: Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging—initial experience publication-title: Radiology – volume: 52 start-page: 1638 year: 2003 end-page: 1643 ident: bib1 article-title: Liver fibrosis is not associated with steatosis but with necro-inflammation in French patients with chronic hepatitis C publication-title: Gut – volume: 89 start-page: 1269 year: 2009 end-page: 1339 ident: bib39 article-title: The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair publication-title: Physiol Rev – volume: 134 start-page: 1376 year: 2008 ident: 10.1016/j.crad.2013.12.003_bib9 article-title: Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.02.075 – volume: 46 start-page: 141 year: 2011 ident: 10.1016/j.crad.2013.12.003_bib30 article-title: Double-dose gadoxetic acid-enhanced magnetic resonance imaging in patients with chronic liver disease publication-title: Invest Radiol doi: 10.1097/RLI.0b013e3181f9c487 – volume: 19 start-page: 1513 year: 1994 ident: 10.1016/j.crad.2013.12.003_bib25 article-title: Classification of chronic hepatitis: diagnosis, grading and staging publication-title: Hepatology doi: 10.1002/hep.1840190629 – volume: 47 start-page: 135 year: 2002 ident: 10.1016/j.crad.2013.12.003_bib28 article-title: Assessment of hepatic perfusion parameters with dynamic MRI publication-title: Magn Reson Med doi: 10.1002/mrm.10045 – volume: 52 start-page: 1638 year: 2003 ident: 10.1016/j.crad.2013.12.003_bib1 article-title: Liver fibrosis is not associated with steatosis but with necro-inflammation in French patients with chronic hepatitis C publication-title: Gut doi: 10.1136/gut.52.11.1638 – volume: 16 start-page: 407 year: 2002 ident: 10.1016/j.crad.2013.12.003_bib37 article-title: Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions publication-title: J Magn Reson Imaging doi: 10.1002/jmri.10176 – volume: 54 start-page: 23 year: 2000 ident: 10.1016/j.crad.2013.12.003_bib34 article-title: A note on concordance correlation coefficient publication-title: PDA J Pharm Sci Technol – volume: 246 start-page: 926 year: 2008 ident: 10.1016/j.crad.2013.12.003_bib10 article-title: Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging—initial experience publication-title: Radiology doi: 10.1148/radiol.2463070077 – volume: 45 start-page: 255 year: 1989 ident: 10.1016/j.crad.2013.12.003_bib33 article-title: A concordance correlation coefficient to evaluate reproducibility publication-title: Biometrics doi: 10.2307/2532051 – volume: 46 start-page: 2050 year: 2000 ident: 10.1016/j.crad.2013.12.003_bib6 article-title: Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring publication-title: Clin Chem doi: 10.1093/clinchem/46.12.2050 – volume: 97 start-page: 2614 year: 2002 ident: 10.1016/j.crad.2013.12.003_bib5 article-title: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2002.06038.x – volume: 45 start-page: 507 year: 2007 ident: 10.1016/j.crad.2013.12.003_bib3 article-title: Chronic hepatitis B publication-title: Hepatology doi: 10.1002/hep.21513 – volume: 22 start-page: 171 year: 2012 ident: 10.1016/j.crad.2013.12.003_bib23 article-title: Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients publication-title: Eur Radiol doi: 10.1007/s00330-011-2249-5 – volume: 11 start-page: 307 year: 2012 ident: 10.1016/j.crad.2013.12.003_bib20 article-title: Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function? publication-title: Hepatobiliary Pancreat Dis Int doi: 10.1016/S1499-3872(12)60165-9 – volume: 56 start-page: 736 year: 2007 ident: 10.1016/j.crad.2013.12.003_bib4 article-title: The incidence and risks of liver biopsy in non-cirrhotic patients: an evaluation of 3806 biopsies publication-title: Gut doi: 10.1136/gut.2006.115410 – volume: 258 start-page: 821 year: 2011 ident: 10.1016/j.crad.2013.12.003_bib38 article-title: Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission publication-title: Radiology doi: 10.1148/radiol.10100995 – volume: 89 start-page: 1269 year: 2009 ident: 10.1016/j.crad.2013.12.003_bib39 article-title: The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair publication-title: Physiol Rev doi: 10.1152/physrev.00027.2008 – volume: 7 start-page: e32622 year: 2012 ident: 10.1016/j.crad.2013.12.003_bib7 article-title: A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B publication-title: PLoS One doi: 10.1371/journal.pone.0032622 – volume: 47 start-page: 649 year: 2012 ident: 10.1016/j.crad.2013.12.003_bib18 article-title: Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic Acid publication-title: Invest Radiol doi: 10.1097/RLI.0b013e3182652fb9 – volume: 47 start-page: 470 year: 2012 ident: 10.1016/j.crad.2013.12.003_bib19 article-title: Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve publication-title: J Gastroenterol doi: 10.1007/s00535-011-0513-8 – volume: 81 start-page: 1100 year: 2012 ident: 10.1016/j.crad.2013.12.003_bib21 article-title: Quantitative analysis of liver function using superparamagnetic iron oxide- and Gd-EOB-DTPA-enhanced MRI: comparison with technetium-99m galactosyl serum albumin scintigraphy publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2011.02.053 – volume: 37 start-page: 1109 year: 2013 ident: 10.1016/j.crad.2013.12.003_bib40 article-title: Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol publication-title: J Magn Reson Imaging doi: 10.1002/jmri.23907 – volume: 229 start-page: 409 year: 2003 ident: 10.1016/j.crad.2013.12.003_bib29 article-title: Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension publication-title: Radiology doi: 10.1148/radiol.2292021128 – volume: 23 start-page: 174 year: 2013 ident: 10.1016/j.crad.2013.12.003_bib15 article-title: Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA publication-title: Eur Radiol doi: 10.1007/s00330-012-2583-2 – volume: 263 start-page: 874 year: 2012 ident: 10.1016/j.crad.2013.12.003_bib11 article-title: Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging publication-title: Radiology doi: 10.1148/radiol.12110337 – volume: 47 start-page: 760 year: 2007 ident: 10.1016/j.crad.2013.12.003_bib8 article-title: The clinical significance of persistently normal ALT in chronic hepatitis B infection publication-title: J Hepatol doi: 10.1016/j.jhep.2007.07.022 – volume: 46 start-page: 277 year: 2011 ident: 10.1016/j.crad.2013.12.003_bib17 article-title: Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging publication-title: Invest Radiol doi: 10.1097/RLI.0b013e318200f67d – volume: 176 start-page: 667 year: 2001 ident: 10.1016/j.crad.2013.12.003_bib27 article-title: Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity publication-title: AJR Am J Roentgenol doi: 10.2214/ajr.176.3.1760667 – volume: 22 start-page: 845 year: 2012 ident: 10.1016/j.crad.2013.12.003_bib14 article-title: Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT publication-title: Eur Radiol doi: 10.1007/s00330-011-2316-y – volume: 259 start-page: 142 year: 2011 ident: 10.1016/j.crad.2013.12.003_bib16 article-title: Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging—preliminary observations publication-title: Radiology doi: 10.1148/radiol.10100621 – volume: 56 start-page: 607 year: 2001 ident: 10.1016/j.crad.2013.12.003_bib36 article-title: Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies publication-title: Clin Radiol doi: 10.1053/crad.2001.0762 – volume: 197 start-page: 399 year: 2011 ident: 10.1016/j.crad.2013.12.003_bib13 article-title: Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.10.5439 – volume: 124 start-page: 97 year: 2003 ident: 10.1016/j.crad.2013.12.003_bib2 article-title: Progression of fibrosis in chronic hepatitis C publication-title: Gastroenterology doi: 10.1053/gast.2003.50018 – volume: 36 start-page: 664 year: 2012 ident: 10.1016/j.crad.2013.12.003_bib22 article-title: MR prediction of liver fibrosis using a liver-specific contrast agent: Superparamagnetic iron oxide versus Gd-EOB-DTPA publication-title: J Magn Reson Imaging doi: 10.1002/jmri.23691 – volume: 22 start-page: 696 year: 1995 ident: 10.1016/j.crad.2013.12.003_bib24 article-title: Histological grading and staging of chronic hepatitis publication-title: J Hepatol doi: 10.1016/0168-8278(95)80226-6 – volume: 22 start-page: 2153 year: 2012 ident: 10.1016/j.crad.2013.12.003_bib12 article-title: MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation publication-title: Eur Radiol doi: 10.1007/s00330-012-2486-2 – volume: 24 start-page: 289 year: 1996 ident: 10.1016/j.crad.2013.12.003_bib26 article-title: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group publication-title: Hepatology doi: 10.1002/hep.510240201 – volume: 44 start-page: 305 year: 2009 ident: 10.1016/j.crad.2013.12.003_bib32 article-title: Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA publication-title: Invest Radiol doi: 10.1097/RLI.0b013e3181a24512 – volume: 3 start-page: 91 year: 2009 ident: 10.1016/j.crad.2013.12.003_bib35 article-title: Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples publication-title: Curr Med Imaging Rev doi: 10.2174/157340507780619179 – volume: 196 start-page: W18 year: 2011 ident: 10.1016/j.crad.2013.12.003_bib31 article-title: Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.10.4387 |
SSID | ssj0009424 |
Score | 2.1063757 |
Snippet | To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with... Aim To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 473 |
SubjectTerms | Adult Alanine Transaminase - blood Area Under Curve Aspartate Aminotransferases - blood China - epidemiology Contrast Media Female Gadolinium DTPA Hepatitis, Chronic - enzymology Hepatitis, Chronic - immunology Hepatitis, Chronic - pathology Humans Liver - blood supply Liver - enzymology Liver - pathology Magnetic Resonance Imaging Male Middle Aged Necrosis Perfusion Imaging Predictive Value of Tests Prospective Studies Radiology Reference Standards Reproducibility of Results Sensitivity and Specificity Severity of Illness Index |
Title | Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0009926013005722 https://www.clinicalkey.es/playcontent/1-s2.0-S0009926013005722 https://dx.doi.org/10.1016/j.crad.2013.12.003 https://www.ncbi.nlm.nih.gov/pubmed/24556468 https://www.proquest.com/docview/1512555455 |
Volume | 69 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1365-229X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009424 issn: 0009-9260 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect customDbUrl: eissn: 1365-229X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009424 issn: 0009-9260 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect Journals customDbUrl: eissn: 1365-229X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009424 issn: 0009-9260 databaseCode: AIKHN dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection (subscription) customDbUrl: eissn: 1365-229X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009424 issn: 0009-9260 databaseCode: ACRLP dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1365-229X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009424 issn: 0009-9260 databaseCode: AKRWK dateStart: 19600101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIiEuiDfLozISNxRaO34k3Kqq1Ra0PSAq9WYZewyp2uxqsysBB34Cv5mZxFmECkXiGMejSTIPT-yZbxh7KTWQ_dlChboulAyhqEqvC1yrfRI2mBRoa2B2Yqan6u2ZPttiB2MtDKVVZt8_-PTeW-eR3fw1dxdNQzW-GN0QIhYhrltJfpjQv1CnX3__leZRK6nGbmo0OxfODDleYekJLVSU_Zbg2Djr6uL0t-CzX4SO7rDbOXrk-8MD3mVb0N5jN2f5fPw--zEFypAOvMVocF6g9qDAh-JE7tvIqZgcg8vILygdg0P77esldG_44Qbzm9PGLJ-9P-YLWKY17aXx5rJvZTTc-uTj_AtVPnIfmsiblocBX5d_7nmvmo5nsNbuATs9OvxwMC1yx4UiKCNXhFUaap2EqaGSCYTcU1BFWdY6pBqgDsJWKdHJnwE0ZRW0EjGqSoUQpcCJD9l2O2_hMeOVjdaWJoLHX1Cw0UefjEExlXsRbJ0mTIyf2oUMR05dMS7cmHd27kg8jsTjhCQQ0wl7taFZDGAc184uRwm6scwUHaPDteJaKvsnKuiybXdOuA5nuiv6N2F6Q_mbCv-T44tRvRzaNh3Y-Bbma-SE0ZjGeE_rCXs06N3mvSWOGmWqJ__J9Sm7hVdqyN18xrZXyzU8x_hq9XGnN6AddmP_-N305CejkiSS |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZhA20vpe9unyr0VkwiWQ-7txASvE12DyWB3ISqR-OSeJf1LiT9Ef3NnbHlLSVtCr1aGmRrHhqPZr4h5D2XAfVPZ8KVZSa4c1mRW5nBWW0j005Fh6GB6UxVp-LTmTzbIvtDLQymVSbb39v0zlqnJztpN3cWdY01vuDdICIWIq5rDnZ4W0iwySOyvTc5qma_sHcFF0NDNSRItTN9mpdbWgQMZXkXFRx6Z908n_7mf3bn0OEDcj85kHSvf8eHZCs0j8idaboif0x-VAGTpB1twCGcZyBAwPO-PpHaxlOsJwf_0tMLzMigofl-fRnaj_RgA_tNMTZLp58ndBGWcY3hNFpfdt2M-qGv1s-vsPiRWld7WjfU9RC79Lxbe1W3NOG1tk_I6eHByX6VpaYLmROKrxCu1JUyMlWGgsfA-K4Ihed5KV0sQygd00WMePmnAmizcLDl3otCOOc5g4lPyaiZN-E5oYX2WufKBwt_oUF7621UCjiV7_qgyzgmbNhq4xIiOTbGuDBD6tk3g-wxyB7DOOKYjsmHDc2ix-O4dXY-cNAMlaZgGw0cF7dS6T9RhTapd2uYaWGmuSGCYyI3lL9J8T9XfDeIlwH1xjsb24T5GlYCh0yCyyflmDzr5W7z3RyeKqGKF_-56ltytzqZHpvjyezoJbkHI6JP5XxFRqvlOrwGd2v15U1Sp59_MSc9 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatic+necro-inflammation+and+elevated+liver+enzymes%3A+Evaluation+with+MRI+perfusion+imaging+with+gadoxetic+acid+in+chronic+hepatitis+patients&rft.jtitle=Clinical+radiology&rft.au=Chen%2C+B.-B.&rft.au=Hsu%2C+C.-Y.&rft.au=Yu%2C+C.-W.&rft.au=Kao%2C+J.-H.&rft.date=2014-05-01&rft.issn=0009-9260&rft.volume=69&rft.issue=5&rft.spage=473&rft.epage=480&rft_id=info:doi/10.1016%2Fj.crad.2013.12.003&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_crad_2013_12_003 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00099260%2FS0009926014X00048%2Fcov150h.gif |